Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Lower risk of metabolic syndrome and fatty liver in gastric cancer survivors: A propensity score-matched analysis.
Authors
Hyojin Park
Gangnam Severance Hospital, Gangnam-Gu, Korea, Republic of (South);
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Symptoms, Toxicities, and Whole-Person Care
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 334)
DOI
10.1200/JCO.2023.41.4_suppl.334
Abstract #
334
Poster Bd #
D15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
A novel cell-free multi-omics approach for enhancing multi-cancer early detection.
First Author: Thien-Chi Van Van Nguyen
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Gastrointestinal cancer trends in the Hispanic population: A SEER database population study (2000-2019).
First Author: Sharon Hechter
Poster
2022 ASCO Annual Meeting
Clinical and radiographic characteristics of patients with metastatic breast cancer and pseudocirrhosis: A single-center retrospective cohort study.
First Author: Laura Ann Huppert
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Trends in long-term survival after liver resection for gastric cancer liver metastasis: Analysis of a single-center experience over 28 years.
First Author: Hiromichi Ito